Clinical trials recruiting for Pulmonary Hypertension Due to Lung Diseases and Hypoxia
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| LAM-001 | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| Alabama | 2 |
| Arizona | 2 |
| Kansas | 2 |
| California | 1 |
| Colorado | 1 |
| Connecticut | 1 |
| District of Columbia | 1 |
| Florida | 1 |
| Georgia | 1 |
| Illinois | 1 |
| Indiana | 1 |
| Kentucky | 1 |
Top cities
Self-screener
Recruiting trials
- DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Giessen Pulmonary Hypertension in Lung Cancer Registry
- LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
- Pulmonary Hypertension Biorepository and Registry
- Ventilator Pressure and Optimization of Compliance and Hemodynamics
Related conditions
Trials recruiting for Pulmonary Hypertension Due to Lung Diseases and Hypoxia often also study these conditions. Each links to its own recruiting-trial list.
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Pulmonary Hypertension Due to Lung Diseases and Hypoxia trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.